No Fire Sale: Allergan May Sell Women’s Health, Infectious Disease Units

Admitting these two areas are relatively small portions of Allergan overall, CEO Brent Saunders says it’s not yet time to consider a company split that would break off the Botox-centered aesthetic medicine portfolio as a separate business.